Ocular and Systemic Pseudoexfoliation Syndrome

American Journal of Ophthalmology

Volumn 141, Issue 5, 2006, Pages

  Schlötzer Schrehardt, Ursula ^a   Naumann, Gottfried O H ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; CYANOCOBALAMIN; EYE PROTEIN; FOLIC ACID; LATANOPROST; MELANIN; PYRIDOXINE; TIMOLOL; TRANSFORMING GROWTH FACTOR BETA1;

ABDOMINAL AORTA ANEURYSM; AGING; ALZHEIMER DISEASE; ANGINA PECTORIS; ARTICLE; BRAIN ISCHEMIA; CAPSULOTOMY; CARDIOVASCULAR DISEASE; CATARACT; CATARACT EXTRACTION; CILIARY BODY; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; CORNEA; DISEASE SEVERITY; EYE DISEASE; EYE SYNECHIA; GENE EXPRESSION; GENETIC RISK; HEART INFARCTION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; HYPHEMA; INTRAOCULAR HYPERTENSION; IRIS; KERATOPATHY; LASER SURGERY; LENS; LENS IMPLANT; LENS SUBLUXATION; MIOSIS; MYDRIASIS; MYOCARDIAL DISEASE; OCCLUSIVE CEREBROVASCULAR DISEASE; OPEN ANGLE GLAUCOMA; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; POSTOPERATIVE CARE; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; PSEUDOEXFOLIATION; PSEUDOEXFOLIATION SYNDROME; RETINA VEIN OCCLUSION; RISK ASSESSMENT; RISK REDUCTION; SENILE DEMENTIA; STROKE; SURGICAL RISK; SYSTEMIC DISEASE; TRABECULAR MESHWORK; TRABECULECTOMY; TRABECULOPLASTY; TREATMENT INDICATION; UVEITIS; VITAMIN BLOOD LEVEL;

EID: 33646168600     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.01.047     Document Type: Article

References (114)

1. Ritch R., and Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol 45 (2001) 265-315
2. Lindberg J.G. Clinical investigations on depigmentation of the pupillary border and translucency of the iris. Acta Ophthalmol 67 suppl 190 (1989) 1-96
3. Vogt A. Ein neues Spaltlampenbild des Pupillengebiets. Hellblauer Pupillensaumfilz mit Häutchenbildung auf der Linsenvorderkapsel. Klein Monatsbl Augenheilkd 75 (1925) 1-12
4. Naumann G.O.H., Schlötzer-Schrehardt U., and Küchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. intraocular and systemic manifestations. Ophthalmology 105 (1998) 951-968
5. Schlötzer-Schrehardt U., and Naumann G.O.H. A histopathologic study of zonular instability in pseudoexfoliation syndrome. Am J Ophthalmol 118 (1994) 730-743
6. Ritch R. Exfoliation syndrome and occludable angles. Trans Am Ophthalmol Soc 92 (1994) 845-944
7. Von der Lippe I., Küchle M., and Naumann G.O.H. Pseudoexfoliation syndrome as a risk factor for acute ciliary block angle closure glaucoma. Acta Ophthalmol 71 (1993) 277-279
8. Asano N., Schlötzer-Schrehardt U., and Naumann G.O.H. A histopathologic study of iris changes in pseudoexfoliation syndrome. Ophthalmology 102 (1995) 1279-1290
9. Helbig H., Schlötzer-Schrehardt U., Noske W., Kellner U., Foerster M.H., and Naumann G.O.H. Anterior chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. German J Ophthalmol 3 (1994) 148-153
10. Küchle M., Nguyen N., and Hannappel E. The blood-aqueous barrier in eyes with pseudoexfoliation syndrome. Ophthalmic Res 27 suppl 1 (1995) 136-142
11. Nguyen N.X., Küchle M., Martus P., and Naumann G.O.H. Quantification of blood-aqueous barrier breakdown after trabeculectomy. pseudoexfoliation versus primary open-angle glaucoma. J Glaucoma 8 (1999) 18-23
12. Schumacher S., Nguyen N.X., Küchle M., and Naumann G.O.H. Quantification of aqueous flare after phacoemulsification with intraocular lens implantation in eyes with pseudoexfoliation syndrome. Arch Ophthalmol 117 (1999) 733-735
13. Schlötzer-Schrehardt U., and Naumann G.O.H. Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. a morphometric, ultrastructural study. Invest Ophthalmol Vis Sci 36 (1995) 1750-1764
14. Gottanka J., Flügel-Koch C., and Martus P. Correlation of pseudoexfoliative material and optic nerve damage in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 38 (1997) 2435-2446
15. Cobb C.J., Blanco G., and Spaeth G.L. Exfoliation syndrome angle characteristics. a lack of correlation with amount of disc damage. Br J Ophthalmol 88 (2004) 1002-1003
16. Yüksel N., Karabas V.L., Arslan A., Demirci A., and Caglar Y. Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology 108 (2001) 1043-1049
17. Harju M., and Vesti E. Blood flow of the optic nerve head and peripapillary retina in exfoliation syndrome with unilateral glaucoma or ocular hypertension. Graefes Arch Clin Exp Ophthalmol 239 (2001) 271-277
18. Ocakoglu O., Koyluoglu N., Kayiran A., Tamcelik N., and Ozkan S. Microvascular blood flow of the optic nerve head and peripapillary retina in unilateral exfoliation syndrome. Acta Ophthalmol Scand 82 (2004) 49-53
19. Netland P.A., Ye H., Streeten B.W., and Hernandez M.R. Elastosis of the lamina cribrosa in pseudoexfoliation syndrome with glaucoma. Ophthalmology 102 (1995) 878-886
20. Puska P., Vesti E., Tomita G., Ishida K., and Raitta C. Optic disc changes in normotensive persons with unilateral exfoliation syndrome. a 3-year follow-up study. Graefes Arch Clin Exp Ophthalmol 237 (1999) 457-462
21. Naumann G.O.H., and Schlötzer-Schrehardt U. Keratopathy in pseudoexfoliation syndrome as a cause of corneal endothelial decompensation. a clinicopathologic study. Ophthalmology 107 (2000) 1111-1124
22. Prince A.M., Streeten B.W., and Ritch R. Preclinical diagnosis of pseudoexfoliation syndrome. Arch Ophthalmol 105 (1987) 1076-1082
23. Inazumi K., Takahashi D., Taniguchi T., and Yamamoto T. Ultrasound biomicroscopic classification of zonules in exfoliation syndrome. Jpn J Ophthalmol 46 (2002) 502-509
24. Mardin C.Y., Schlötzer-Schrehardt U., and Naumann G.O.H. "Masked" pseudoexfoliation syndrome in unoperated eyes with circular posterior synechiae. Arch Ophthalmol 119 (2001) 1500-1504
25. Conway R.M., Schlötzer-Schrehardt U., Küchle M., and Naumann G.O.H. Pseudoexfoliation syndrome. pathologic manifestations of relevance to intraocular surgery. Clin Exp Ophthalmol 32 (2004) 199-210
26. Küchle M., Amberg A., Martus P., Nguyen N.X., and Naumann G.O.H. Pseudoexfoliation syndrome and secondary cataract. Br J Ophthalmol 81 (1997) 862-866
27. Hayashi H., Hayashi K., Nakao F., and Hayashi F. Anterior capsule contraction and intraocular lens dislocation in eyes with pseudoexfoliation syndrome. Br J Ophthalmol 82 (1998) 1429-1432
28. Bialasiewicz A.A., Wali U., Shenoy R., and Al-Saeidi R. Cataract patients with pseudoexfoliation (PEX) syndrome among a population with high prevalence of PEX. Clinical findings and morphological and surgical characteristics. Ophthalmologe 102 (2005) 1181-1185
29. Guzek J.P., Holm M., Cotter J.B., et al. Risk factors for intraoperative complications in 1000 extracapsular cataract cases. Ophthalmology 94 (1987) 461-466
30. Akman A., Yilmaz G., Oto S., and Akova Y.A. Comparison of various pupil dilatation methods for phacoemulsification in eyes with a small pupil secondary to pseudoexfoliation. Ophthalmology 111 (2004) 1693-1698
31. Küchle M., Viestenz A., Martus P., Händel A., Jünemann A., and Naumann G.O.H. Anterior chamber depth and complications during cataract surgery in eyes with pseudoexfoliation syndrome. Am J Ophthalmol 129 (2000) 281-285
32. Nihalani B.R., Jani U.D., Vasavada A.R., and Auffahrt G.U. Cataract surgery in relative anterior microphthalmos. Ophthalmology 112 (2005) 1360-1367
33. Moreno-Montanes J., and Rodriguez-Conde R. Capsular tension ring in eyes with pseudoexfoliation. J Cat Refract Surg 28 (2002) 2241-2242
34. Katsimpris J.M., Petropoulos I.K., Apostolakis K., and Feretis D. Comparing phacoemulsification and extracapsular cataract extraction in eyes with pseudoexfoliation syndrome, small pupil, and phacodonesis. Klin Monatsbl Augenheilkd 221 (2004) 328-333
35. Nagashima R.J. Decreased incidence of capsule complications and vitreous loss during phacoemulsification in eyes with pseudoexfoliation syndrome. J Cataract Refract Surg 30 (2004) 127-131
36. Hyams M., Mathalone N., Herskovitz M., Hod Y., Israeli D., and Geyer O. Intraoperative complications of phacoemulsification in eyes with and without pseudoexfoliation. J Cataract Refract Surg 31 (2005) 1002-1005
37. Jehan F.S., Mamalis N., and Crandall A.S. Spontaneous late dislocation of intraocular lens within the capsular bag in pseudoexfoliation patients. Ophthalmology 108 (2001) 1727-1731
38. Masket S., and Osher R.H. Late complications with intraocular lens dislocation after capsulorhexis in pseudoexfoliation syndrome. J Cataract Refract Surg 28 (2002) 1481-1484
39. Ritch R. Exfoliation syndrome. the most common identifiable cause of open-angle glaucoma. J Glaucoma 3 (1996) 176-178
40. Bialasiewicz A.A., Wali U., Shenoy R., and Al-Saeidi R. Patients with secondary open-angle glaucoma in pseudoexfoliation (PEX) syndrome among a population with high prevalence of PEX. clinical findings and morphological and surgical characteristics. Ophthalmologe 102 (2005) 1064-1068
41. Konstas A.G.P., Stewart W.C., and Stromann G.A. Clinical presentation and initial treatment patterns in patients with exfoliation glaucoma versus primary open-angle glaucoma. Ophthalmol Surg Lasers 28 (1997) 111-117
42. Konstas A.G.P., Mantziris D.A., and Stewart W.C. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol 115 (1997) 182-185
43. Lanzl I.M., Merte R.L., and Graham A.D. Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome?. J Glaucoma 9 (2000) 214-218
44. Teus M.A., Castejon M.A., and Calvo M.A. Intraocular pressure as a risk factor for visual field loss in pseudoexfoliative and in primary open-angle glaucoma. Ophthalmology 105 (1998) 2225-2229
45. Gumus K., Bozkurt B., Sonmez B., Irkec M., Orhan M., and Saracbasi O. Diurnal variation of intraocular pressure and its correlation with retinal nerve fiber analysis in Turkish patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol (2005) 1-7 Aug 2, (Epub ahead of print)
46. Bergea B., Bodin L., and Svedbergh B. Impact of intraocular pressure regulation on visual fileds in open-angle glaucoma. Ophthalmology 106 (1999) 997-1004
47. Konstas A.G.P., Hollo G., Astakhov Y.S., et al. Factors associated with long-term progression or stability in exfoliation glaucoma. Arch Ophthalmol 122 (2004) 29-33
48. Konstas A.G.P., Mylopoulos N., Karabatsas C.H., et al. Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma. Eye 18 (2004) 893-899
49. Altintas O., Yüksel N., Karabas V.L., and Caglar Y. Diurnal intraocular pressure variation in pseudoexfoliation syndrome. Eur J Ophthalmol 14 (2004) 495-500
50. Inoue K., Okugawa K., Oshika T., and Amano S. Morphological study of corneal endothelium and corneal thickness in pseudoexfoliation syndrome. Jpn J Ophthalmol 47 (2003) 235-239
51. Grodum K., Heijl A., and Bengtsson B. Risk of glaucoma in ocular hypertension with and without pseudoexfoliation. Ophthalmology 112 (2005) 386-390
52. Puska P.M. Unilateral exfoliation syndrome. conversion to bilateral exfoliation and to glaucoma-a prospective 10-year follow-up study. J Glaucoma 11 (2002) 517-524
53. Jonas J.B., and Papastathopoulos K.I. Optic disc appearance in pseudoexfoliation syndrome. Am J Ophthalmol 123 (1997) 174-180
54. Konstas A.G.P., Koliakos G.G., Liakos P., et al. Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humor of patients with exfoliative glaucoma. Exp Eye Res 82 (2005) 319-322
55. Threlkeld A.B., Hertzmark E., and Sturm R.T. Comparative study of the efficacy of argon laser trabeculoplasty for exfoliation and primary open-angle glaucoma. J Glaucoma 5 (1996) 311-316
56. Jacobi P.C., and Krieglstein G.K. Trabecular aspiration. a new mode to treat pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 36 (1995) 2271-2276
57. Grüb M., Mielke J., Rohrbach J.M., and Schlote T. Trabecular aspiration in pseudoexfoliative glaucoma-surgery to primarily reduce intraocular pressure. Klin Monatsbl Augenheilkd 219 (2002) 353-357
58. Krupin T., Feitl M.E., and Bishop K.I. Postoperative intraocular pressure rise in open-angle glaucoma patients after cataract or combined cataract-filtration surgery. Ophthalmology 96 (1989) 579-584
59. Merkur A., Damji K.F., Mintsioulis G., and Hodge W.G. Intraocular pressure decrease after phacoemulsification in patients with pseudoexfoliation syndrome. J Cataract Refract Surg 27 (2001) 528-532
60. Schlötzer-Schrehardt U., Koca M., Naumann G.O.H., and Volkholz H. Pseudoexfoliation syndrome. ocular manifestation of a systemic disorder?. Arch Ophthalmol 110 (1992) 1752-1756
61. Streeten B.W., Li Z.-Y., Wallace R.N., Eagle R.C., and Keshgegian A.A. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 110 (1992) 1757-1762
62. Schlötzer-Schrehardt U., Küchle M., Hofmann-Rummelt C., Kaiser A., and Kirchner T.H. Latent TGF-β1 binding protein (LTBP-1). a new marker for intra- und extraocular PEX deposits. Klin Monatsbl Augenheilkd 216 (2000) 412-419
63. Repo L.P., Teräsvirta M.E., and Koivisto K.J. Generalized transluminance of the iris and the frequency of the pseudoexfoliation syndrome in the eyes of transient ischemic attack patients. Ophthalmology 100 (1993) 352-355
64. Mitchell P., Wang J.J., and Smith W. Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124 (1997) 685-687
65. Schumacher S., Schlötzer-Schrehardt U., Martus P., Lang W., and Naumann G.O.H. Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet 357 (2001) 359-360
66. Bojic L., Ermacora R., Polic S., et al. Pseudoexfoliation syndrome and asymptomatic myocardial dysfunction. Graefes Arch Clin Exp Ophthalmol 243 (2005) 446-449
67. Linner E., Popovic V., Gottfries C.-G., Jonsson M., Sjögren M., and Wallin A. The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type. Acta Ophthalmol Scand 79 (2001) 283-285
68. Cahill M., Early A., Stack S., Blayney A.W., and Eustace P. Pseudoexfoliation and sensorineural hearing loss. Eye 16 (2002) 261-266
69. Ritland J.S., Egge K., Lydersen S., Juul R., and Semb S.O. Exfoliative glaucoma and primary open-angle glaucoma. associations with death causes and comorbidity. Acta Ophthalmol Scand 82 (2004) 401-404
70. Allingham R.R., Loftsdottir M., Gottfredsdottir M.S., et al. Pseudoexfoliation syndrome in Icelandic families. Br J Ophthalmol 85 (2001) 702-707
71. Ringvold A., Blika S., and Sandvik L. Pseudoexfoliation and mortality. Acta Ophthalmol Scand 75 (1997) 255-256
72. Shrum K.R., Hattenhauer M.G., and Hodge D. Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 129 (2000) 83-86
73. Bleich S., Jünemann A., von Ahsen N., et al. Homocysteine and risk of open-angle glaucoma. J Neural Transm 109 (2002) 499-1504
74. Leibovitch I., Kurtz S., Shemesh G., et al. Hyperhomocysteinemia in pseudoexfoliation glaucoma. J Glaucoma 12 (2003) 36-39
75. Vessani R.M., Ritch R., Liebmann J., and Jofe M. Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol 136 (2003) 41-46
76. Puustjärvi T., Blomster H., Kontkanen M., Punnonen K., and Teräsvirta M. Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 242 (2004) 749-754
77. Altintas O., Maral H., Yüksel N., Karabas V.L., Dillioglugil M.O., and Caglar Y. Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 243 (2005) 677-683
78. Jünemann A.G., von Ahsen N., Reulbach U., et al. C677T variant in the methylentetrahydrofolate reductase gene is a genetic risk factor for primary open-angle glaucoma. Am J Ophthalmol 139 (2005) 721-723
79. Ringvold A. A preliminary report on the amino acid composition of the pseudo-exfoliation material (PE material). Exp Eye Res 15 (1973) 37-42
80. Zenkel M., Pöschl E., von der Mark K., et al. Differential gene expression in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 46 (2005) 3742-3752
81. Gartaganis S.P., Georgakopoulos C.D., Exarchou A.M., Mela E.K., Lamari F., and Karamanos N.K. Increased aqueous humor basic fibroblast growth factor and hyaluronan levels in relation to the exfoliation syndrome and exfoliative glaucoma. Acta Ophthalmol Scand 79 (2001) 572-575
82. Hu D.-N., and Ritch R. Hepatocyte growth factor is increased in the aqueous humor of glaucomatous eyes. J Glaucoma 10 (2001) 152-157
83. Schlötzer-Schrehardt U., Zenkel M., Küchle M., Sakai L.Y., and Naumann G.O.H. Role of transforming growth factor-β1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res 73 (2001) 765-780
84. Ho S.L., Dogar G.F., Wang J., et al. Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome. Br J Ophthalmol 89 (2005) 169-173
85. Gartaganis S.P., Georgakopoulos C.D., Mela E.K., et al. Matrix metalloproteinases and their inhibitors in exfoliation syndrome. Ophthalmic Res 34 (2002) 165-171
86. Schlötzer-Schrehardt U., Lommatzsch J., Küchle M., Konstas A.G.P., and Naumann G.O.H. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Invest Ophthalmol Vis Sci 44 (2003) 1117-1125
87. 2A and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 87 (2003) 353-356
88. Koliakos G.G., Konstas A.G.P., Schlötzer-Schrehardt U., et al. Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 88 (2004) 523-527
89. Yilmaz A., Adigüzel U., Tamer L., et al. Serum oxidant/antioxidant balance in exfoliation syndrome. Clin Exp Ophthalmol 33 (2005) 63-66
90. Cursiefen C., Händel A., Schönherr U., and Naumann G.O.H. Pseudoexfoliation syndrome in patients with branch and central retinal vein thrombosis. Klin Monatsbl Augenheilkd 211 (1997) 17-21
91. Gillies W.E., and Brooks A.M.V. Central retinal vein occlusion in pseudoexfoliation of the lens capsule. Clin Exp Ophthalmol 30 (2002) 176-178
92. Hollo G., Lakatos P., and Farkas K. Cold pressure test and plasma endothelin-1 concentration in primary open-angle and capsular glaucoma. J Glaucoma 7 (1998) 105-110
93. Akarsu C., and Ünal B. Cerebral haemodynamics in patients with pseudoexfoliation glaucoma. Eye 19 (2005) 1297-1300
94. Kotikoski H., Moilanen E., Vapaatalo H., and Aine E. Biochemical markers of the l-arginine-nitric oxide pathway in the aqueous humour in glaucoma patients. Acta Ophthalmol Scand 80 (2002) 191-195
95. Bleich S., Roedl J., von Ahsen N., et al. Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol 138 (2004) 162-164
96. Streeten B.W., Gibson S.A., and Dark A.J. Pseudoexfoliative material contains an elastic microfibrillar-associated glycoprotein. Trans Am Ophthalmol Soc 84 (1986) 304-320
97. Wilson M.R., and Easterbrook-Smith S.B. Clusterin is a secreted mammalian chaperone. Trends Biochem Sci 25 (2000) 95-98
98. Lee S., Lee S., and Sharma K. The pathogenesis of fibrosis and renal disease in scleroderma. recent insights from glomerulosclerosis. Curr Rheumatol Rep 6 (2004) 141-148
99. Ringvold A. Epidemiology of the pseudoexfoliation syndrome. Acta Ophthalmol Scand 77 (1999) 371-375
100. Forsius H., Forsman E., Fellman J., and Eriksson A.W. Exfoliation syndrome. frequency, gender distribution and association with climatically induced alterations of the cornea and conjunctiva. Acta Ophthalmol Scan 80 (2002) 478-484
101. Damji K.F., Bains H.S., Stefansson E., et al. Is pseudoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation. Ophthalmic Genetics 19 (1998) 175-185
102. Orr A.C., Robitaille J.M., Price P.A., et al. Exfoliation syndrome. clinical and genetic features. Ophthalmic Genet 22 (2001) 171-185
103. Hardie J.G., Mercieca F., Fenech T., and Cuschieri A. Familial pseudoexfoliation in Gozo. Eye 19 (2005) 1280-1285
104. Kozobolis V.P., Detorakis E.T., Sourvinos G., Pallikaris I.G., and Spandidos D.A. Loss of heterozygosity in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 40 (1999) 1255-1260
105. Zalewska R., Pepinski W., Smolenska-Janica D., et al. Loss of heterozygosity in patients with pseudoexfoliation syndrome. Mol Vis 9 (2003) 257-261
106. Küchle M., and Naumann G.O.H. Occurrence of pseudoexfoliation following penetrating keratoplasty for keratoconus. Br J Ophthalmol 76 (1992) 98-100
107. Tarkkanen A., and Kivelä T. Cumulative incidence of converting from clinically unilateral to bilateral exfoliation syndrome. J Glaucoma 13 (2004) 181-184
108. Kivelä T., Hietanen J., and Uusitalo M. Autopsy analysis of clinically unilateral exfoliation syndrome. Invest Ophthalmol Vis Sci 38 (1997) 2008-2015
109. Hammer T.H., Schlötzer-Schrehardt U., and Naumann G.O.H. Unilateral or asymmetric pseudoexfoliation syndrome? An ultrastructural study. Arch Ophthalmol 119 (2001) 1023-1031
110. Ritch R., and Schlötzer-Schrehardt U. Exfoliation (pseudoexfoliation) syndrome. toward a new understanding. Proceedings of the First International Think Tank. Acta Ophthalmol Scand 79 (2001) 213-217
111. Berlau J., Lorenz P., Beck R., et al. Analysis of aqueous humour proteins of eyes with and without pseudoexfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 239 (2001) 743-746
112. Janciauskiene S., and Krakau T. Alzheimer's peptide. a possible link between glaucoma, exfoliation syndrome and Alzheimer's disease. Acta Ophthalmol Scand 79 (2001) 328-329
113. Yilmaz A., Tamer L., Ates N.A., Camdeviren H., and Degirmenci U. Effects of apolipoprotein E genotypes on the development of exfoliation syndrome. Exp Eye Res 80 (2005) 871-875
114. Schlötzer-Schrehardt U., Zenkel M., Decking U., et al. Selective upregulation of the A3 adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma. Invest Ophthalmol Vis Sci 46 (2005) 2023-2034